Mohan Stewart1,2, Jolanda Cibere3,4, Eric C Sayre3, Jacek A Kopec3,5. 1. Department of Medicine, University of British Columbia, 2775 Laurel Street, 10th Floor, Vancouver, BC, V5Z 1M9, Canada. mohanzhong@gmail.com. 2. Arthritis Research Canada, Richmond, BC, Canada. mohanzhong@gmail.com. 3. Arthritis Research Canada, Richmond, BC, Canada. 4. Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. 5. Division of Epidemiology, Biostatistics, and Public Health Practice, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Abstract
OBJECTIVE: Pain management is a cornerstone of osteoarthritis (OA) management. The aim of this review is to obtain current, literature-based estimates of the effect of common pharmacologic treatments on pain reduction in OA. METHODS: A MEDLINE search (2006-2016) was conducted for randomized controlled trials studying acetaminophen, oral NSAIDs, topical NSAIDs, COX-2 inhibitors, and opioids in the treatment of OA pain. Drug effect on pain was estimated using relative change in pain, and expressed as percentage change. An overall effect for each drug category was obtained as a weighted average of study-specific effects, with weights based on each study's sample size. RESULTS: Twenty-nine studies were included. The effect on pain was estimated in a total of 43 treatment arms (acetaminophen n = 6, oral NSAIDs n = 9, topical NSAIDs n = 8, COX-2 inhibitors n = 9, and opioids n = 11). Relative (%) changes in pain were found to be as follows: acetaminophen = 32.5, oral NSAIDs = 34.3, topical NSAIDs = 40.9, COX-2 inhibitors = 36.9, and opioids = 35.4. CONCLUSION: The effects of 5 major drug categories in the treatment of OA pain were reviewed with data extracted from 29 studies published from 2006 to 2016. Acetaminophen was found to have an RC value close to that of oral NSAIDs. The effects of oral NSAIDs, COX-2 inhibitors, and opioids in controlling pain were similar to what has been demonstrated in previous literature. Topical NSAIDs were found to have a greater RC than oral NSAIDs.
OBJECTIVE:Pain management is a cornerstone of osteoarthritis (OA) management. The aim of this review is to obtain current, literature-based estimates of the effect of common pharmacologic treatments on pain reduction in OA. METHODS: A MEDLINE search (2006-2016) was conducted for randomized controlled trials studying acetaminophen, oral NSAIDs, topical NSAIDs, COX-2 inhibitors, and opioids in the treatment of OA pain. Drug effect on pain was estimated using relative change in pain, and expressed as percentage change. An overall effect for each drug category was obtained as a weighted average of study-specific effects, with weights based on each study's sample size. RESULTS: Twenty-nine studies were included. The effect on pain was estimated in a total of 43 treatment arms (acetaminophen n = 6, oral NSAIDs n = 9, topical NSAIDs n = 8, COX-2 inhibitors n = 9, and opioids n = 11). Relative (%) changes in pain were found to be as follows: acetaminophen = 32.5, oral NSAIDs = 34.3, topical NSAIDs = 40.9, COX-2 inhibitors = 36.9, and opioids = 35.4. CONCLUSION: The effects of 5 major drug categories in the treatment of OA pain were reviewed with data extracted from 29 studies published from 2006 to 2016. Acetaminophen was found to have an RC value close to that of oral NSAIDs. The effects of oral NSAIDs, COX-2 inhibitors, and opioids in controlling pain were similar to what has been demonstrated in previous literature. Topical NSAIDs were found to have a greater RC than oral NSAIDs.
Authors: Byron P DeLemos; Jim Xiang; Carmela Benson; Theophilus J Gana; Maria Luz G Pascual; R Rosanna; B Fleming Journal: Am J Ther Date: 2011-05 Impact factor: 2.688
Authors: Bruno R da Costa; Stephan Reichenbach; Noah Keller; Linda Nartey; Simon Wandel; Peter Jüni; Sven Trelle Journal: Lancet Date: 2017-07-08 Impact factor: 79.321
Authors: Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams Journal: N Engl J Med Date: 2006-02-23 Impact factor: 91.245
Authors: Ernest R Vina; Philip H Tsoukas; Shahrzad Abdollahi; Nidhi Mody; Stephanie C Roth; Albert H Redford; C Kent Kwoh Journal: Ther Adv Musculoskelet Dis Date: 2022-06-30 Impact factor: 3.625
Authors: Jacek A Kopec; Eric C Sayre; Anya Okhmatovskaia; Jolanda Cibere; Linda C Li; Nick Bansback; Hubert Wong; Shahzad Ghanbarian; John M Esdaile Journal: PLoS One Date: 2021-12-08 Impact factor: 3.240